The amygdala is a small, almond-shaped group of nuclei located deep within the temporal lobes of the brain that is part of the limbic system, which is involved in processing emotions, memories, and decision-making.
The functions of the amygdala are processing emotional responses, particularly fear and anxiety, the formation and storage of memories associated with emotional events, role in decision-making, specifically in situations involving rewards and punishments, and modulating the activity of other brain regions, such as the hippocampus and prefrontal cortex, which are involved in memory and cognition.
The disorders involved in amygdala dysfunction are anxiety disorders, mood disorders, autism spectrum disorder, depression, schizophrenia, impulse control disorders, and Alzheimer’s disease.
The amygdala is a brain structure within the limbic system that plays a key role in emotional processing. Unlike the neocortex, the brain’s outer layer responsible for higher cognitive functions like visual processing and language, the amygdala is located in the brain’s internal, or subcortical region.
It comprises multiple nuclei, including the basolateral complex, the central nucleus, and the corticomedial nuclei. Each of these nuclei contributes to the amygdala’s diverse functions in emotional regulation, memory formation, and social behavior.
In 2016, Méndez-Bértolo et al. published A Fast Pathway for Fear in Human Amygdala, revealing that the amygdala can detect potential threats in the visual environment at ultra-fast time scales. This groundbreaking discovery was made by an international team of scientists led by researchers from the Campus de Excelencia Internacional Moncloa (UCM-UPM). By measuring the electrical activity in the amygdala of epilepsy patients with implanted electrodes, the researchers provided new insights into how information travels between the visual and emotional networks.
This new understanding of how information travels between the visual system and emotional networks offers better insights into conditions characterized by heightened fear, such as phobias and anxiety, where the amygdala is critical.
The amygdala’s role in addiction is drug-related memories, stress and drug cues, connectivity with the prefrontal cortex, and the central nucleus of the amygdala (CeA) as offered by Patel et al. (2020) in IL-10 normalizes aberrant amygdala GABA transmission and reverses anxiety-like behavior and dependence-induced escalation of alcohol intake:
The amygdala functions are emotion processing, fear and stress response, memory formation, addiction and relapse, and social cognition, as elaborated by Wang et al. (2024) in Reply to ‘Fear, anxiety and the functional architecture of the human central extended amygdala’:
The amygdala processes emotions like fear, anger, anxiety, pleasure, and emotional responses. It addresses emotional learning through fear conditioning, helping individuals to associate specific stimuli with emotional reactions. Additionally, the amygdala attributes emotional significance to memories, decisions, and attention, influencing how experiences are perceived and remembered based on their emotional content.
The amygdala detects threats and initiates the fight-or-flight response, triggering physiological reactions through its connections to the hypothalamus and brainstem. It integrates the influence of stress on emotional processing, regulating how stress affects our emotional responses and behaviors.
The amygdala links emotions to memories by forming connections with the hippocampus. It is actively involved in both the consolidation and reconsolidation of emotional memories, particularly fear-related memories, influencing how these memories are stored and recalled over time.
The basolateral amygdala is instrumental in processing drug-related memories and cues, which significantly contribute to relapse in addiction. In various addiction disorders, encompassing substance addictions and behavioral addictions like internet addiction, alterations in amygdala connectivity have been observed, highlighting its role in reinforcing addictive behaviors and responses to addictive stimuli.
The amygdala recognizes emotions within oneself and in others. It is intricately associated with social behaviors through its connections with the prefrontal cortex and hypothalamus, governing aspects of emotional expression, empathy, and social interaction.
The amygdala is involved in the pathophysiology of several neurological and psychiatric disorders, which are anxiety disorders, depression, autism spectrum disorder, schizophrenia, Alzheimer’s disease, and temporal lobe epilepsy, as propounded by Stevens et al. (2017) in Amygdala Reactivity and Anterior Cingulate Habituation Predict Posttraumatic Stress Disorder Symptom Maintenance After Acute Civilian Trauma and expanded below:
The amygdala plays a central role in processing fear and anxiety. Hyperactivity of the amygdala is observed in anxiety disorders like generalized anxiety disorder, panic disorder, and post-traumatic stress disorder (PTSD).
Altered amygdala function and structure, including reduced volume, is linked to major depressive disorder. The amygdala’s role in emotional processing and regulation contributes to the symptoms of depression.
Abnormal amygdala development, including enlargement in young children with autism, is a common finding. Amygdalar dysfunction likely contributes to the social and emotional deficits seen in autism.
Structural and functional changes in the amygdala, such as reduced volume, have been reported in schizophrenia. Amygdalar abnormalities may relate to the emotional and social cognitive deficits in schizophrenia.
Atrophy of the amygdala and the hippocampus is an early feature of Alzheimer’s disease. Amygdalar damage contributes to the memory problems and personality changes seen in Alzheimer’s.
Seizures originating in the temporal lobe, where the amygdala is located, can cause damage to the amygdala. This generates mood disturbances, irritability, and aggression in some patients with temporal lobe epilepsy.
Get confidential help 24/7. Call now for:
Related Articles
Get Help Now
Medical Advice Disclaimer
Magnified Health Systems aims to improve the quality of life for people struggling with substance use or mental health disorder with fact-based content about the nature of behavioral health conditions, treatment options and their related outcomes. We publish material that is researched, cited, edited and reviewed by licensed medical professionals. The information we provide is not intended to be a substitute for professional medical advice, diagnosis or treatment. It should not be used in place of the advice of your physician or other qualified healthcare providers.
Dr. Bickley graduated from U.C. Irvine with honors: Phi Beta Kappa, Golden Key International Honor Society, Cum Laude. He has been featured on national radio and print media. He is also a frequent lecturer at National Conferences. He holds an A.S. degree in Drug & Alcohol Studies, and two B.A. degrees in Criminology & Psychology, and masters and doctoral degree in Clinical Psychology. He is a licensed California Drug & Alcohol Counselor Level II, a licensed Clinical Supervisor and is certified in treating Eating Disorders.
